Title
Sentinel lymph node biopsy with blue patent more imprinted in the axillary stage of breast cancer in a hospital of high complexity
Other title
Biopsia de ganglio centinela con azul patente más impronta en el estadiaje axilar de cáncer de mama en un hospital de alta complejidad
Date Issued
30 June 2021
Access level
open access
Resource Type
journal article
Author(s)
Servicio de Cirugía Oncológica del Hospital de Alta Complejidad
Publisher(s)
Medical Body of the Almanzor Aguinaga Asenjo National Hospita
Abstract
Objetive: To analyze the main clinical-pathological characteristics of patients with breast carcinoma in whom a sentinel lymph node biopsy was performed with patent blue plus imprint in the axillary staging. The study. This descriptive series evaluated a series of 20 cases of patients with an anatomopathological diagnosis of infiltrating ductal carcinoma treated in the area of Oncological Surgery of the Hospital of High Complexity "Virgen de la Puerta" EsSalud, La Libertad - Peru, during the period February 2017 until January 2018. Findings: The sensitivity and specificity of the sentinel lymph node imprint was 75% respectively. The positive and negative predictive value was 67% and 82% respectively. The positive and negative likelihood ratio was 3.0 and 0.33. The Kappa index was 0.2 of considered as a concordance index. Conclusions. The sentinel lymph node technique is a good alternative for the management of breast cancer, since it avoids unnecessary surgical interventions.
Start page
190
End page
194
Volume
14
Issue
2
Language
Spanish
OCDE Knowledge area
Patología
Oncología
Subjects
Scopus EID
2-s2.0-85124231864
Source
Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
ISSN of the container
22255109
DOI of the container
10.35434/rcmhnaaa.2021.142.1064
Sources of information:
Directorio de Producción Científica
Scopus